Noraker
Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regeneration
Highlights
- New on EvolcAdded 2026-10-30
About Noraker
Noraker designs, manufactures and markets implantable medical devices made from synthetic, resorbable biomaterials for bone regeneration and osteosynthesis. Its products include bioactive-glass granules and injectable putties, as well as calcium phosphate cement.
Its devices are used by surgeons in orthopaedics, spine surgery, craniomaxillofacial and ENT surgery, and dentistry. The company is based in Lyon and was founded in 2005.
Product: Implantable bone-regeneration and osteosynthesis devices, including bioactive-glass granules and putties and calcium phosphate cement.
Public tenders won
4 tenders won since 1 Jan 2024 from 3 public buyers in France, worth €977.0M as awarded. From EU award notices (TED) that name Noraker by its registry number.
- 13 May 2025 Centre hospitalier GHT AUDE-PYRENEES · APPEL D'OFFRES OUVERT N°04 PH 24 notice
- 20 Mar 2025 GIP RESAH · Fourniture d'implants d'orthopédie, pour prothèses articulaires, pour ostéosynthèse, pour ligamentoplastie, de ciment orthopédique, de greffons et substituts osseux et prêt des ancillaires associés. · €471.3M notice
- 13 Mar 2025 GIP RESAH · Fourniture d'implants d'orthopédie, pour prothèses articulaires, pour ostéosynthèse, pour ligamentoplastie, de ciment orthopédique, de greffons et substituts osseux et prêt des ancillaires associés. · €471.3M notice
- 4 Jun 2024 CHU DE SAINT ETIENNE · N° DMS 2023-01 / AO090 · €34.3M notice
Jobs at Noraker
Leadership
- Céline Saint Olive · CEOSource: company website
- Mickaël Pulici · Chief operation OfficerSource: company website
More biotech & pharma companies
Novalix
Preclinical drug discovery services for biotechnology and pharmaceutical companiesNew on EvolcNovaptech
Custom aptamer development, assays and biosensors for biotechnology, pharmaceutical, academic and agri-food organizationsNew on EvolcOddifact
AI platform that prepares orphan drug programs for rare diseases and hands them to pharma partners for developmentYoung companyNew on EvolcOncodesign Services
Preclinical CRO running in vivo pharmacology, imaging and radiopharmaceutical studies for biotech and pharma sponsorsNew on EvolcRemote-friendlyOne Biosciences
Single-cell tumour profiling from biopsy samples for oncologists and pharma and biotech drug developersNew on EvolcOrakl Oncology
Oncology drug discovery and clinical-response prediction for biopharma companies and research hospitalsYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- CookieYes
- Elementor
- Google reCAPTCHA
- PHP
- WordPress
- jQuery
